Various
investment entities and individuals have been active in the acquisition, sale, and adjustment of positions in
Sempra's (NYSE:SRE) stock, indicating a dynamic market environment.
Cynthia J. Warner purchased 700 shares,
Charles Schwab Investment Management Inc. acquired, and Keybank National Association boosted their stake. Meanwhile, Reaves W H & Co. Inc. sold 269,414 shares and Bahl & Gaynor Inc. sold 209,949 shares. Despite a
14% dip following revised earnings guidance and lowered price target to $78 at BMO Capital Markets, Jim Cramer remained optimistic, highlighting Sempra as a 'sleeper stock with growth and yield.' On a negative note, a
fraud investigation has been launched against Sempra, prompting investor caution. Top executives have also been seen making significant moves in the company's stock. Sempra announced a
common dividend and showcased a strategic growth plan during their Q4 2024 earnings call. However, Q4 earnings didn't meet estimates and the company lowered its 2025 EPS outlook. Conversely, Sempra was named one of the world's most admired companies, and despite a share price slip, the company's fundamentals remain solid. The various events have spurred discussions concerning the company's investment potential, with analysts projecting an 8.10% price increase ahead.
Sempra SRE News Analytics from Mon, 14 Oct 2024 07:00:00 GMT to Sun, 09 Mar 2025 00:01:50 GMT -
Rating 0
- Innovation 2
- Information 8
- Rumor -5
